Neuroimmune disorders in COVID-19 Helena AriñoRosie HeartshorneAlberto Vogrig Review Open access 30 March 2022 Pages: 2827 - 2839
Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosis Alice MariottiniAndrea BertozziAnna Maria Repice Original Communication 03 March 2022 Pages: 2840 - 2847
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination Francesca Schiano di ColaSalvatore CaratozzoloRenata Rao Letter to the Editors 08 January 2022 Pages: 2848 - 2849
Neuromyelitis optica spectrum disorder following COVID-19 infection with increase in pre-existing anti-aquaporin-4 antibodies Alexandre JentzerClarisse Carra-DallièreThierry Vincent Letter to the Editors 22 January 2022 Pages: 2850 - 2853
Characterization of cognitive impairment in adult polyglucosan body disease Paul Theo ZebhauserIsabell CordtsMarcus Deschauer Review Open access 08 January 2022 Pages: 2854 - 2861
Voxel-based meta-analysis of gray matter abnormalities in idiopathic dystonia Xiang HuangJunyu LinJing Yang Review 11 January 2022 Pages: 2862 - 2873
Efficacy and safety of VNS therapy or continued medication management for treatment of adults with drug-resistant epilepsy: systematic review and meta-analysis Sarah BatsonRohit ShankarVanessa Danielson Review Open access 16 January 2022 Pages: 2874 - 2891
Levodopa-induced dyskinesia: a historical review of Parkinson’s disease, dopamine, and modern advancements in research and treatment Carissa A. HansenDouglas R. MillerHabibeh Khoshbouei Review 17 January 2022 Pages: 2892 - 2909
Emerging technologies for management of patients with amyotrophic lateral sclerosis: from telehealth to assistive robotics and neural interfaces Raffaele PuglieseRiccardo SalaChristian Lunetta Review 21 January 2022 Pages: 2910 - 2921
Fitness, physical activity, and exercise in multiple sclerosis: a systematic review on current evidence for interactions with disease activity and progression Sebastian ProschingerPuya KuhwandNiklas Joisten Review Open access 27 January 2022 Pages: 2922 - 2940
Instrumented gait analysis defines the walking signature of CACNA1A disorders Elisabetta IndelicatoCecilia RaccagniSylvia Boesch Original Communication Open access 09 November 2021 Pages: 2941 - 2947
White matter connectivity networks predict levodopa-induced dyskinesia in Parkinson’s disease Jin Ho JungYae Ji KimPhil Hyu Lee Original Communication 11 November 2021 Pages: 2948 - 2960
Functional MRI connectivity of the primary motor cortex in functional dystonia patients Noemi PiramideElisabetta SarassoFederica Agosta Original Communication 12 November 2021 Pages: 2961 - 2971
Head-impulse tests aid in differentiation of multiple system atrophy from Parkinson’s disease Jae-Gyum KimSung-Hwan KimKun-Woo Park Original Communication 12 November 2021 Pages: 2972 - 2979
Hypothalamic subregion abnormalities are related to body mass index in patients with sporadic amyotrophic lateral sclerosis Shuangwu LiuQingguo RenChuanzhu Yan Original Communication 15 November 2021 Pages: 2980 - 2988
Brain structural abnormalities in the preclinical stage of Machado–Joseph disease/spinocerebellar ataxia type 3 (MJD/SCA3): evaluation by MRI morphometry, diffusion tensor imaging and neurite orientation dispersion and density imaging Mengcheng LiXinyuan ChenJianping Hu Original Communication 16 November 2021 Pages: 2989 - 2998
A clinical study of 288 patients with anterior cerebral artery infarction Hyunji ChoTaewon KimHansol Im Original Communication 16 November 2021 Pages: 2999 - 3005
The role of frailty in Parkinson’s disease: a cross-sectional study Daniele BelvisiMarco CanevelliGiovanni Fabbrini Original Communication 17 November 2021 Pages: 3006 - 3014
Risk factors for poor outcomes of spontaneous supratentorial cerebral hemorrhage after surgery Kangwei ZhangLai WeiPeijun Wang Original Communication Open access 17 November 2021 Pages: 3015 - 3025
Altered brain network functional connectivity patterns in patients with vestibular migraine diagnosed according to the diagnostic criteria of the Bárány Society and the International Headache Society Zhe-Yuan LiLi-Hong SiXu Yang Original Communication Open access 18 November 2021 Pages: 3026 - 3036
TBK1 haploinsufficiency results in changes in the K63-ubiquitination profiles in brain and fibroblasts from affected and presymptomatic mutation carriers Behzad KhoshnoodAbbe UllgrenCaroline Graff Original Communication Open access 20 November 2021 Pages: 3037 - 3049
Burden of disease in myasthenia gravis: taking the patient’s perspective Sophie LehnererJonas JacobiAndreas Meisel Original Communication Open access 20 November 2021 Pages: 3050 - 3063
Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus Maria Boge LauvsnesHenrik ZetterbergRoald Omdal Original Communication 20 November 2021 Pages: 3064 - 3074
Potential risk factors of persistent postural-perceptual dizziness: a pilot study Ling LiSongbin HeFangyu Dai Original Communication 20 November 2021 Pages: 3075 - 3085
Causes of symptom dissatisfaction in patients with generalized myasthenia gravis Linda Kahr AndersenAnna Sofie JakobssonJohn Vissing Original Communication 21 November 2021 Pages: 3086 - 3093
The complexities of CACNA1A in clinical neurogenetics Marina P. HommersomTeije H. van ProoijeBart P. C. van de Warrenburg Original Communication 22 November 2021 Pages: 3094 - 3108
When should we test patients with epilepsy for autoimmune antibodies? Results from a French retrospective single center study Bondish KambadjaHouot MarionDupont Sophie Original Communication 23 November 2021 Pages: 3109 - 3118
Ictal semiology of epileptic seizures with insulo-opercular genesis Eva Martinez-LizanaArmin BrandtAndreas Schulze-Bonhage Original Communication Open access 23 November 2021 Pages: 3119 - 3128
The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI Elena Di SabatinoLorenzo GaetaniMassimiliano Di Filippo Original Communication 24 November 2021 Pages: 3129 - 3135
Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated disease Tetsuya AkaishiTatsuro MisuIchiro Nakashima Original Communication Open access 25 November 2021 Pages: 3136 - 3146
Population-attributable fractions of risk factors for all-cause dementia in China rural and urban areas: a cross-sectional study Fei-fei HuGui-rong ChengYan Zeng Original Communication 28 November 2021 Pages: 3147 - 3158
MRI of the intraspinal nerve roots in patients with chronic inflammatory neuropathies: abnormalities correlate with clinical phenotypes Marieke H. J. van RosmalenMartijn FroelingH. Stephan Goedee Original Communication 06 January 2022 Pages: 3159 - 3166
Genetic and phenotypic variability in adult patients with Niemann Pick type C from Serbia: single-center experience Nikola KresojevićValerija DobričićVladimir S. Kostić Original Communication 07 January 2022 Pages: 3167 - 3174
Isolated spinal cord granulomatous angiitis: a case report and review of the literature Cansu Ayvacıoğlu CaganCagri Mesut TemucinM. Akif Topçuoğlu Original Communication 09 January 2022 Pages: 3175 - 3179
Transient neurological deficit in patients with chronic subdural hematoma: a retrospective cohort analysis Jurre BlaauwHeleen M. den HertogBram Jacobs Original Communication 09 January 2022 Pages: 3180 - 3188
Tract-specific damage at spinal cord level in pure hereditary spastic paraplegia type 4: a diffusion tensor imaging study Francisco J. Navas-SánchezLuis Marcos-VidalManuel Desco Original Communication 09 January 2022 Pages: 3189 - 3203
Towards consensus on visual pursuit and visual fixation in patients with disorders of consciousness. A Delphi study Berno U. H. OverbeekJan C. M. LavrijsenRaymond T. C. M. Koopmans Original Communication 10 January 2022 Pages: 3204 - 3215
Peripapillary retinal nerve fiber layer thinning in patients with progressive supranuclear palsy Kyung Ah WooJoo Young ShinJee-Young Lee Original Communication Open access 18 December 2021 Pages: 3216 - 3225
Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regression Dimitrios PapadopoulosPanagiotis GklinosRichard S. Nicholas Original Communication 23 January 2022 Pages: 3226 - 3237
Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome María Paz Guerrero-MolinaMontserrat Morales-ConejoJesús González de la Aleja Original Communication 28 January 2022 Pages: 3238 - 3248
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis Eleonora VirgilioDomizia VecchioCristoforo Comi Original Communication 28 January 2022 Pages: 3249 - 3257
Gender disparity and abuse in functional movement disorders: a multi-center case-control study Isaiah KletenikSamantha K. HoldenJon Stone Original Communication 31 January 2022 Pages: 3258 - 3263
Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen Silvia BonannoRiccardo ZaninLorenzo Maggi Original Communication 03 January 2022 Pages: 3264 - 3275
Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany Tjalf ZiemssenMichael Langthe PANGAEA study group Original Communication Open access 04 January 2022 Pages: 3276 - 3285
Higher baseline blood glucose is associated with reduced likelihood for successful recanalization in patients with basilar artery occlusion Gabriel BroocksMaximilian GroffmannUta Hanning Original Communication Open access 04 January 2022 Pages: 3286 - 3294
Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study Kévin BigautLaurent KremerJérôme de Seze Original Communication 04 January 2022 Pages: 3295 - 3300
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study Antonio Riccardo BuonomoGiulio ViceconteRaising Italian Researchers in Multiple Sclerosis (RIREMS) study group Original Communication Open access 14 February 2022 Pages: 3301 - 3307
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study Antonio Riccardo BuonomoGiulio ViceconteRaising Italian Researchers in Multiple Sclerosis (RIREMS) study group Correction Open access 04 April 2022 Pages: 3308 - 3309
Managing freezing of gait in Parkinson’s disease: a systematic review and network meta-analysis Jojo Yan Yan KwokRobert SmithBastiaan R. Bloem Original Communication 04 March 2022 Pages: 3310 - 3324
Correction to: Managing freezing of gait in Parkinson’s disease: a systematic review and network meta-analysis Jojo Yan Yan KwokRobert SmithBastiaan R. Bloem Correction 05 April 2022 Pages: 3325 - 3327
